Marshall Wace, LLP Boston Scientific Corp Call Options Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BSX
# of Institutions
1,319Shares Held
1.17BCall Options Held
5.92MPut Options Held
5.75M-
Vanguard Group Inc Valley Forge, PA127MShares$9.81 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY127MShares$9.77 Billion0.21% of portfolio
-
State Street Corp Boston, MA62.7MShares$4.83 Billion0.19% of portfolio
-
Massachusetts Financial Services CO Boston, MA46.6MShares$3.59 Billion0.99% of portfolio
-
Primecap Management CO Pasadena, CA37.9MShares$2.92 Billion1.97% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $110B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...